Skip to main content
. 2023 Jun 27;12(13):4301. doi: 10.3390/jcm12134301

Figure 1.

Figure 1

Blockade of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed death protein 1/Ligand 1 (PD-1/L1) in cancer immunotherapy. The figure is adapted from Ribas, 2012 [39] and created using icons from biorender.com (accessed 12 February 2023).